146 related articles for article (PubMed ID: 18301332)
1. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database.
Mindikoglu AL; Regev A; Magder LS
Transplantation; 2008 Feb; 85(3):359-68. PubMed ID: 18301332
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
[TBL] [Abstract][Full Text] [Related]
3. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
4. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
[TBL] [Abstract][Full Text] [Related]
5. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
8. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database.
Mindikoglu AL; Magder LS; Regev A
Liver Transpl; 2009 Jul; 15(7):719-29. PubMed ID: 19562705
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
Bénet T; D'Oliveira A; Voirin N; Livrozet JM; Cotte L; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Allard R; Vanhems P
J Viral Hepat; 2007 Oct; 14(10):730-5. PubMed ID: 17875008
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
[TBL] [Abstract][Full Text] [Related]
11. Poor survival after liver retransplantation: is hepatitis C to blame?
Watt KD; Lyden ER; McCashland TM
Liver Transpl; 2003 Oct; 9(10):1019-24. PubMed ID: 14526394
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
13. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
15. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome.
Yoo HY; Maheshwari A; Thuluvath PJ
Liver Transpl; 2003 Sep; 9(9):897-904. PubMed ID: 12942450
[TBL] [Abstract][Full Text] [Related]
16. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
Thuluvath PJ; Krok KL; Segev DL; Yoo HY
Liver Transpl; 2007 May; 13(5):719-24. PubMed ID: 17457933
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003.
Hong Z; Smart G; Dawood M; Kaita K; Wen SW; Gomes J; Wu J
Transplant Proc; 2008 Jun; 40(5):1466-70. PubMed ID: 18589130
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
19. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
[TBL] [Abstract][Full Text] [Related]
20. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]